Frontiers in Pharmacology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-12-24 12099d61m86(暂无昵称) 来自重庆

审稿速度:2.0 | 投稿命中率:95.0
经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。
22 Dec 2023
Article accepted for publication.
Review of Review Editor 1 finalized.
19 Dec 2023
You posted new comments.
Submitting Author re-submitted manuscript.
You posted new comments.
Submitting Author posted new comments in the Editor tab.
12 Dec 2023
Interactive review forum activated automatically.
06 Dec 2023
Review of Reviewer 2 is finalized.
20 Nov 2023
Submitting Author submitted manuscript.

58 0

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-12-18 ms6000000645412256 来自四川省

偏重的研究方向：民族药理学
经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-12-17 Anlan0924 来自江苏省

偏重的研究方向：中药药理;中药复方
经验分享：这个杂志要不要求wb条带整膜？

64 0

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-12-16 145f93d9m65暂无昵称来自山东省

meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月

54 0

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-10-11 科研-小白来自山西省

Initial Validation大家用了多久，我提交原始数据第5天没动静

159 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-09-28 jobhnw 来自安徽省

自引率6.3，国人占比100%，会踢么

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-10-10 桑葚大友来自山东省

请问大家review finalized以后几天？最后结果如何，谢谢大家。

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-08-25 1378327198@qq.com 来自湖南省

请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2022-12-08 南山晓月ZARD 来自辽宁省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：Meta分析
经验分享：请问发表后pubmed上能检索到需要多长时间？

144 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176894, encodeId=8b2721e6894b3, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：Original article. 非常愉快的一次投稿，历时一个月多几天。分享下经验。要毕业的小朋友值得投。 22 Dec 2023 Article accepted for publication. Review of Review Editor 1 finalized. 19 Dec 2023 You posted new comments. Submitting Author re-submitted manuscript. You posted new comments. Submitting Author posted new comments in the Editor tab. 12 Dec 2023 Interactive review forum activated automatically. 06 Dec 2023 Review of Reviewer 2 is finalized. 20 Nov 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3c2192972, createdName=12099d61m86(暂无昵称), createdTime=Sun Dec 24 19:35:15 CST 2023, time=2023-12-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2175671, encodeId=b78721e567136, content=偏重的研究方向：民族药理学 经验分享：家人们，请问review finalized 要等多久才能accept呀，真的太着急了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Mon Dec 18 19:30:34 CST 2023, time=2023-12-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2175473, encodeId=58a021e547343, content=偏重的研究方向：中药药理;中药复方 经验分享：这个杂志要不要求wb条带整膜？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211106/3c6d5dbb10fc4ac6a18ac9c5a37a278f/d78ef2797c1f46948fcb50b0f2a0574e.jpg, createdBy=01bd5605455, createdName=Anlan0924, createdTime=Sun Dec 17 15:53:47 CST 2023, time=2023-12-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2175299, encodeId=2fe721e529955, content=meta分析，三个审稿人，两个人接受一个拒稿，最后接受。及时2月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Dec 16 16:41:31 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2162179, encodeId=7a9d21621e99f, content=Initial Validation大家用了多久，我提交原始数据第5天没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=726d8808692, createdName=科研-小白, createdTime=Wed Oct 11 14:04:09 CST 2023, time=2023-10-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2160142, encodeId=9cd721601429f, content=自引率6.3，国人占比100%，会踢么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Thu Sep 28 08:20:17 CST 2023, time=2023-09-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2162001, encodeId=d220216200127, content=请问大家review finalized以后几天？最后结果如何，谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3618230763, createdName=桑葚大友, createdTime=Tue Oct 10 17:13:05 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154508, encodeId=cb0c215450890, content=请问有要求提供组学分析代码的吗？相关图片生成是组学相关生物公司提供的，人家也不给代码啊，我这是不是得撤稿了，没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305447324, createdName=1378327198@qq.com, createdTime=Fri Aug 25 10:39:50 CST 2023, time=2023-08-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2104998, encodeId=98d12104998f3, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：Meta分析 经验分享：请问发表后pubmed上能检索到需要多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep1HeUOlIoagypwfVbQuVCiaGM87PvQBWTmHPYNkic30KtOA1YZZyxrQUobKbQ545FAicyXQ6khht0vQ/132, createdBy=37681676512, createdName=南山晓月ZARD, createdTime=Thu Dec 08 22:30:08 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158271, encodeId=dc8121582e17c, content=补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Mon Sep 18 12:21:29 CST 2023, time=2023-09-18, status=1, ipAttribution=浙江省)]

2023-09-18 重复的用户名来自浙江省

补充材料有表格和图片。请问，图片是单独上传，还是放在WORD里和表格一起上传？

51 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务